濮阳东方医院收费低濮阳东方价格合理,濮阳东方医院男科割包皮价格不贵,濮阳东方妇科医院专家怎么样,濮阳东方在线挂号,濮阳东方咨询专家在线,濮阳东方医院治疗早泄口碑非常高,濮阳东方医院男科看阳痿

BEIJING, March 13 (Xinhua) -- China's top legislator Wu Bangguo on Sunday met and extended regards to the journalists of leading Chinese media covering the annual sessions of the top legislature and advisory body."You have given full coverage on important issues such as the review of the draft 12th Five-Year Plan and the scheduled establishment of the socialist system of laws with Chinese characteristics," Wu said to the journalists.The stories written by the journalists " fully tell how lawmakers and political advisers performed their deputies, and reflect people's wishes and aspiration," said Wu, chairman of the Standing Committee of the 11th National People's Congress (NPC).Wu said that he expected the public media will do a better job in covering issues regarding to the political development path with Chinese characteristics and the people's congress system.The fourth session of the NPC will conclude on Monday morning, and the fourth session of the National Committee of the Chinese People's Political Consultative Conference ended Sunday.

LOS ANGELES, April 3 (Xinhua) -- People with lower levels of vitamin D are more likely to have stiffer arteries and an inability of blood vessels to relax, U.S. researchers have found.This finding also applies to people who are in general good health, according to researchers from the Emory University School of Medicine.The researchers presented their findings on Sunday at the annual American College of Cardiology meeting in New Orleans.Impaired vascular health in correlation with lower vitamin D levels contributes to high blood pressure and the risk of cardiovascular disease, the researchers say.The study involved 554 participants, with the average age of 47 and generally healthy.The average level of 25-hydroxyvitamin D (a stable form of the vitamin reflecting diet as well as production in the skin) in participants' blood was 31.8 nanograms per milliliter. In this group, 14 percent had 25-hydroxyvitamin D levels considered deficient, or less than 20 nanograms per milliliter, and 33 percent had levels considered insufficient, less than 30 nanograms per milliliter.The researchers monitored the ability of participants' blood vessels to relax by inflating and then removing a blood pressure cuff on their arms. To allow blood to flow back into the arm, blood vessels must relax and enlarge -- a change that can be measured by ultrasound. The researchers also made other measurements of smaller blood vessels and examined the resistance to blood flow imposed by the arteries.

BEIJING, Feb. 8 (Xinhua) -- China would continue expanding its radio and television networks coverage in the country's rural areas in the 2011-2015 period, according to the State Administration of Radio, Film and Television (SARFT).In the five-year period, efforts would focus on ensuring access to radio and TV services in those villages with less than 20 households, the SARFT said in a statement.It noted that China's other villages which had more than 20 households were already covered by the radio and TV networks, thanks to government's continuous efforts in this regard.China's central and local governments poured over 15.7 billion yuan (2.38 billion U.S. dollars) into the upgrading of the radio and TV networks in the country's rural areas in 2006-2010.Official figures indicated that 96.31 percent and 97.23 percent of China's population had access to radio and TV services respectively in 2009. The ratio was 86.02 percent and 87.68 percent respectively in 1997.

MOSCOW, May 24 (Xinhua) -- Russia's Soyuz TMA-20 spacecraft with three crew members onboard has landed in Kazakhstan on Tuesday, said the Mission Control Center (MCC) outside Moscow.The spacecraft undocked from the International Space Station early Tuesday, carrying Russian cosmonaut Dmitry Kondratyev, European Space Agency (ESA) astronaut Paolo Nespoli and NASA astronaut Catherine Coleman back to Earth.According to the center, the Soyuz TMA-20 landed in the Kazakh steppe at 6:27 Moscow time (0227 GMT). Some 17 planes and helicopters and several rescue vehicles had conducted search works.Flight engineers Catherine "Cady" Coleman of the U.S. (L) and Italian Paolo Nespoli (R), and Russian cosmonaut and station commander Dmitry Kondratyev are seen after the Soyuz capsule landed, about 150 km (93 miles) southeast of the Kazakh town of Zhezkazgan May 24, 2011. A Russian Soyuz capsule delivered an international trio of astronauts back to Earth on Tuesday after six months on the International Space Station, parachuting through clear skies toward a safe landing on the Kazakh steppe.Deputy head of Federal Medical and Biological Agency Vyacheslav Rogozhkin said Italian astronaut Naspoli had some health problem after landing."Two crew members are fine, the third one has some problems with his vestibular system," Rogozhkin told a press conference after the landing.In December, the Soyuz TMA-20 was launched from the Kazakh Baikonur space center with three crew members.The next launch of manned spacecraft to the ISS was scheduled in early June.

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.